Showing results (341-350 of 390) with videos related to

Sort By:
Pageof 39
Nature Medicine|February 25, 2014
In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's diseaseRaja Atreya, Helmut Neumann, Clemens Neufert, et al.
EMBO Molecular Medicine|May 30, 2025
IL-36 signaling as a drug target in Crohn's disease patients with IL36RN mutationsJulia Hecker, Christina Plattner, Camila A Cancino, et al.
Gastroenterology|July 15, 2019
Inhibiting PGGT1B Disrupts Function of RHOA, Resulting in T-cell Expression of Integrin α4β7 and Development of Colitis in MiceRocío López-Posadas, Petra Fastancz, Luz Del Carmen Martínez-Sánchez, et al.
The New England Journal of Medicine|March 19, 2015
Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's diseaseGiovanni Monteleone, Markus F Neurath, Sandro Ardizzone, et al.
The Journal of Experimental Medicine|May 8, 2002
The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's diseaseM F Neurath, B Weigmann, S Finotto, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|December 18, 2014
High-definition endoscopy with iScan and Lugol's solution for the detection of inflammation in patients with nonerosive reflux disease: histologic evaluation in comparison with a control groupJ W Rey, N Deris, J U Marquardt, et al.
Journal of Crohn'S & Colitis|September 25, 2023
NLRP3 Inhibition Leads to Impaired Mucosal Fibroblast Function in Patients with Inflammatory Bowel DiseasesSimone Weber, Selina Sitte, Anna-Lena Voegele, et al.
Journal of Crohn'S & Colitis|April 28, 2025
Expert recommendations to standardize transcriptomic analysis in inflammatory bowel disease clinical trialsBryan Linggi, Salas Azucena, Boyd Steere, et al.
Pageof 39